XERIS BIOPHARMA HOLDINGS, INC. Shares Outstanding (Cover Page)
XERIS BIOPHARMA HOLDINGS, INC. (XERS) had Shares Outstanding (Cover Page) of 182.32 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 182.32M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 172.64M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 172.43M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 165.92M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 182.32M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 172.64M shares 10-Q · filed 2026-05-07 |
| 2026-02-27 | 172.43M shares 10-K · filed 2026-03-02 |
| 2025-10-31 | 165.92M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 161.48M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 160.16M shares 10-Q · filed 2025-05-08 |
| 2025-02-28 | 153.94M shares 10-K · filed 2025-03-06 |
| 2024-10-31 | 149.08M shares 10-Q · filed 2024-11-08 |
| 2024-07-31 | 149.00M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 148.26M shares 10-Q · filed 2024-05-09 |
| 2024-02-29 | 140.45M shares 10-K · filed 2024-03-06 |
| 2023-10-31 | 138.12M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 138.07M shares 10-Q · filed 2023-08-08 |
| 2023-05-01 | 137.31M shares 10-Q · filed 2023-05-09 |
| 2023-02-28 | 137.29M shares 10-K · filed 2023-03-08 |
| 2022-10-31 | 135.99M shares 10-Q · filed 2022-11-09 |
| 2022-07-31 | 135.96M shares 10-Q · filed 2022-08-10 |
| 2022-04-30 | 135.53M shares 10-Q · filed 2022-05-11 |
| 2022-02-28 | 135.52M shares 10-K · filed 2022-03-11 |
| 2021-10-31 | 124.71M shares 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |